100 results
Page 4 of 5
8-K
EX-99.1
9lya wlm4e2usw4
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
EX-99.1
a5k42mns
16 Mar 21
Akero Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
8:10am
8-K
EX-99.1
3ylmbe7c7bo1s0e2
11 Jan 21
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. JP Morgan Presentation January 2021
7:01am
8-K
EX-99.1
lwts2 c2wvobw
16 Nov 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation November 2020
6:30am
8-K
EX-99.1
zi5ll5tm zbfm498n
12 Nov 20
Akero Therapeutics Reports THIRD Quarter 2020 Financial Results
4:20pm
8-K
EX-99.1
q8f4tg1lek
15 Oct 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation October 2020
8:30am
8-K
EX-99.1
mk0tkeh59os2l3
12 Aug 20
Akero Therapeutics Reports SECOND Quarter 2020 Financial Results
4:25pm
8-K
hffcsx7i9d0
30 Jun 20
Akero Announces Strongly Positive Histological Data
4:16pm
8-K
EX-99.2
60awwrstyb47 m7
30 Jun 20
Akero Announces Strongly Positive Histological Data
4:16pm
8-K
EX-99.1
ma6cyuytp
30 Jun 20
Akero Announces Strongly Positive Histological Data
4:16pm
8-K
eexx3
17 Jun 20
Other Events
8:05am
8-K
EX-99.1
lyv0 crv8tdbh7
28 May 20
Other Events
8:01am
DRS
nligd
15 May 20
Draft registration statement
12:00am
8-K
EX-99.1
9oohpy1t
13 May 20
Akero Therapeutics Reports first Quarter 2020 Financial Results
4:17pm
DEF 14A
rcyi45
27 Apr 20
Definitive proxy
7:30am
8-K
EX-99.1
gpcrmy9 zt2jwv4upy
31 Mar 20
Regulation FD Disclosure
8:25am